News
Barclays raised the firm’s price target on Keurig Dr Pepper (KDP) to $39 from $36 and keeps an Overweight rating on the shares. The firm sensed growing concerns about green coffee pressures ...
Morgan Stanley upgraded shares of Keurig Dr Pepper (NASDAQ:KDP – Free Report) from an equal weight rating to an overweight rating in a research report released on Tuesday, Ratings reports. The firm ...
Eilon Paz / Bloomberg via Getty Images Keurig Dr Pepper has secured a new $4 billion revolving credit agreement. The deal with lenders, issuing banks, and administrative agent JPMorgan Chase ...
Finally, Barclays set a $39.00 target price on Keurig Dr Pepper in a research report on Thursday, February 27th. Six analysts have rated the stock with a hold rating and eight have given a buy ...
The stock's rise snapped a three-day losing streak.
Piper Sandler upgraded Keurig Dr Pepper (KDP) to Overweight from Neutral with a price target of $40, up from $35. The firm cites the company’s ...
We expect Keurig Dr Pepper to generate excess investment returns aided by intangible assets and scale benefits in its soft drink portfolio and entrenched retail and brand partner relationships in ...
February 25, 2025 Keurig Dr Pepper sees higher-than-expected annual profit on strong demand Keurig Dr Pepper on Tuesday forecast annual profit above Wall Street expectations, after beating fourth ...
Investing.com -- Citi analysts named Keurig Dr Pepper (NASDAQ:KDP) as its top overall pick in the beverage sector in a note Thursday, citing strong momentum in its refreshment beverage business ...
Keurig Dr Pepper said the cash from this agreement "may be used for general corporate purposes and working capital." Keurig Dr Pepper (KDP) shares traded near their 2025 highs as the company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results